Cargando…
Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
TGF β-activated kinase 1 (TAK1) is an important participant in inflammatory pathogenesis for diseases such as rheumatoid arthritis (RA) and gouty arthritis. The central position it occupies between the mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) pathways makes it an at...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621335/ https://www.ncbi.nlm.nih.gov/pubmed/34830460 http://dx.doi.org/10.3390/ijms222212580 |
_version_ | 1784605433056460800 |
---|---|
author | Panipinto, Paul M. Singh, Anil K. Shaikh, Farheen S. Siegel, Ruby J. Chourasia, Mukesh Ahmed, Salahuddin |
author_facet | Panipinto, Paul M. Singh, Anil K. Shaikh, Farheen S. Siegel, Ruby J. Chourasia, Mukesh Ahmed, Salahuddin |
author_sort | Panipinto, Paul M. |
collection | PubMed |
description | TGF β-activated kinase 1 (TAK1) is an important participant in inflammatory pathogenesis for diseases such as rheumatoid arthritis (RA) and gouty arthritis. The central position it occupies between the mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) pathways makes it an attractive therapeutic target. As this field has developed in recent years, several novel inhibitors have been presented as having specific activity that reduces the TAK1 function either covalently as in the case of 5Z-7-oxozeanol (5Z7O) or reversibly (NG-25). However, the mechanism through which takinib elicits its anti-inflammatory activity remains elusive. While this inhibitor shows great promise, a thorough analysis of its inhibitor function and its potential off-target effects is necessary before addressing its clinical potential or its use in inflammatory conditions. An analysis through Western blot showed an unexpected increase in IL-1β-induced TAK1 phosphorylation—a prerequisite for and indicator of its functional potential—by takinib while simultaneously demonstrating the inhibition of the JAK/STAT pathway in human rheumatoid arthritis synovial fibroblasts (RASFs) in vitro. In THP-1 monocyte-derived macrophages, takinib again led to the lipopolysaccharide-induced phosphorylation of TAK1 without a marked inhibition of the TAK1 downstream effectors, namely, of c-Jun N-terminal kinase (JNK), phospho-c-Jun, NF-κB phospho-p65 or phospho-IκBα. Taken together, these findings indicate that takinib inhibits inflammation in these cells by targeting multiple signaling pathways, most notably the JAK/STAT pathway in human RASFs. |
format | Online Article Text |
id | pubmed-8621335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86213352021-11-27 Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway Panipinto, Paul M. Singh, Anil K. Shaikh, Farheen S. Siegel, Ruby J. Chourasia, Mukesh Ahmed, Salahuddin Int J Mol Sci Article TGF β-activated kinase 1 (TAK1) is an important participant in inflammatory pathogenesis for diseases such as rheumatoid arthritis (RA) and gouty arthritis. The central position it occupies between the mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) pathways makes it an attractive therapeutic target. As this field has developed in recent years, several novel inhibitors have been presented as having specific activity that reduces the TAK1 function either covalently as in the case of 5Z-7-oxozeanol (5Z7O) or reversibly (NG-25). However, the mechanism through which takinib elicits its anti-inflammatory activity remains elusive. While this inhibitor shows great promise, a thorough analysis of its inhibitor function and its potential off-target effects is necessary before addressing its clinical potential or its use in inflammatory conditions. An analysis through Western blot showed an unexpected increase in IL-1β-induced TAK1 phosphorylation—a prerequisite for and indicator of its functional potential—by takinib while simultaneously demonstrating the inhibition of the JAK/STAT pathway in human rheumatoid arthritis synovial fibroblasts (RASFs) in vitro. In THP-1 monocyte-derived macrophages, takinib again led to the lipopolysaccharide-induced phosphorylation of TAK1 without a marked inhibition of the TAK1 downstream effectors, namely, of c-Jun N-terminal kinase (JNK), phospho-c-Jun, NF-κB phospho-p65 or phospho-IκBα. Taken together, these findings indicate that takinib inhibits inflammation in these cells by targeting multiple signaling pathways, most notably the JAK/STAT pathway in human RASFs. MDPI 2021-11-22 /pmc/articles/PMC8621335/ /pubmed/34830460 http://dx.doi.org/10.3390/ijms222212580 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Panipinto, Paul M. Singh, Anil K. Shaikh, Farheen S. Siegel, Ruby J. Chourasia, Mukesh Ahmed, Salahuddin Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway |
title | Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway |
title_full | Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway |
title_fullStr | Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway |
title_full_unstemmed | Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway |
title_short | Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway |
title_sort | takinib inhibits inflammation in human rheumatoid arthritis synovial fibroblasts by targeting the janus kinase-signal transducer and activator of transcription 3 (jak/stat3) pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621335/ https://www.ncbi.nlm.nih.gov/pubmed/34830460 http://dx.doi.org/10.3390/ijms222212580 |
work_keys_str_mv | AT panipintopaulm takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway AT singhanilk takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway AT shaikhfarheens takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway AT siegelrubyj takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway AT chourasiamukesh takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway AT ahmedsalahuddin takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway |